| Dr Raj B Patel, MD | |
|
901 Adams Blvd, Boulder City, NV 89005-2299 | |
| (702) 293-4111 | |
| Not Available |
| Full Name | Dr Raj B Patel |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 15 Years |
| Location | 901 Adams Blvd, Boulder City, Nevada |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669817656 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Jewish Hospital & St Mary's Healthcare | Louisville, KY | Hospital |
| Baptist Health Paducah | Paducah, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southeastern Emergency Physicians Llc | 2466364997 | 491 |
News Archive
Immunotherapy techniques developed in oncology to combat cancerous cells have great potential for fighting viruses.
Researchers at the Case Western Reserve University School of Medicine, with colleagues from the John P. Hussman Institute for Human Genomics at the University of Miami, Taub Institute for Research on Alzheimer's Disease and the Aging Brain, at Columbia University, and Wake Forest University School of Medicine will study the genomics of Alzheimer's disease (AD) in people with African heritage throughout the United States.
Genzyme Corporation announced results today from its CLASSIC I phase 3 trial comparing Clolar® (clofarabine) in combination with the chemotherapy agent cytarabine (ara-c) to cytarabine plus placebo in relapsed-refractory adult acute myeloid leukemia (AML).
Researchers of Karlsruhe Institute of Technology (KIT) and of the FZI Research Center for Information Technology, an innovation partner of KIT, have now proposed an app that combines the advantages of a central and a decentralized approach and, thus, enhances privacy.
Endo Pharmaceuticals Inc., a subsidiary of Endo Health Solutions Inc. announced today that the U.S. Food and Drug Administration has issued a complete response letter regarding the New Drug Application for Endo's long-acting testosterone undecanoate injection, AVEED, for men diagnosed with hypogonadism.
› Verified 5 days ago
| Entity Name | Southern Medical Partners, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538109962 PECOS PAC ID: 8123923679 Enrollment ID: O20031206000036 |
News Archive
Immunotherapy techniques developed in oncology to combat cancerous cells have great potential for fighting viruses.
Researchers at the Case Western Reserve University School of Medicine, with colleagues from the John P. Hussman Institute for Human Genomics at the University of Miami, Taub Institute for Research on Alzheimer's Disease and the Aging Brain, at Columbia University, and Wake Forest University School of Medicine will study the genomics of Alzheimer's disease (AD) in people with African heritage throughout the United States.
Genzyme Corporation announced results today from its CLASSIC I phase 3 trial comparing Clolar® (clofarabine) in combination with the chemotherapy agent cytarabine (ara-c) to cytarabine plus placebo in relapsed-refractory adult acute myeloid leukemia (AML).
Researchers of Karlsruhe Institute of Technology (KIT) and of the FZI Research Center for Information Technology, an innovation partner of KIT, have now proposed an app that combines the advantages of a central and a decentralized approach and, thus, enhances privacy.
Endo Pharmaceuticals Inc., a subsidiary of Endo Health Solutions Inc. announced today that the U.S. Food and Drug Administration has issued a complete response letter regarding the New Drug Application for Endo's long-acting testosterone undecanoate injection, AVEED, for men diagnosed with hypogonadism.
› Verified 5 days ago
| Entity Name | Pikeville Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528195864 PECOS PAC ID: 6709790157 Enrollment ID: O20040304001281 |
News Archive
Immunotherapy techniques developed in oncology to combat cancerous cells have great potential for fighting viruses.
Researchers at the Case Western Reserve University School of Medicine, with colleagues from the John P. Hussman Institute for Human Genomics at the University of Miami, Taub Institute for Research on Alzheimer's Disease and the Aging Brain, at Columbia University, and Wake Forest University School of Medicine will study the genomics of Alzheimer's disease (AD) in people with African heritage throughout the United States.
Genzyme Corporation announced results today from its CLASSIC I phase 3 trial comparing Clolar® (clofarabine) in combination with the chemotherapy agent cytarabine (ara-c) to cytarabine plus placebo in relapsed-refractory adult acute myeloid leukemia (AML).
Researchers of Karlsruhe Institute of Technology (KIT) and of the FZI Research Center for Information Technology, an innovation partner of KIT, have now proposed an app that combines the advantages of a central and a decentralized approach and, thus, enhances privacy.
Endo Pharmaceuticals Inc., a subsidiary of Endo Health Solutions Inc. announced today that the U.S. Food and Drug Administration has issued a complete response letter regarding the New Drug Application for Endo's long-acting testosterone undecanoate injection, AVEED, for men diagnosed with hypogonadism.
› Verified 5 days ago
| Entity Name | Southeastern Emergency Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356379382 PECOS PAC ID: 2466364997 Enrollment ID: O20050302000285 |
News Archive
Immunotherapy techniques developed in oncology to combat cancerous cells have great potential for fighting viruses.
Researchers at the Case Western Reserve University School of Medicine, with colleagues from the John P. Hussman Institute for Human Genomics at the University of Miami, Taub Institute for Research on Alzheimer's Disease and the Aging Brain, at Columbia University, and Wake Forest University School of Medicine will study the genomics of Alzheimer's disease (AD) in people with African heritage throughout the United States.
Genzyme Corporation announced results today from its CLASSIC I phase 3 trial comparing Clolar® (clofarabine) in combination with the chemotherapy agent cytarabine (ara-c) to cytarabine plus placebo in relapsed-refractory adult acute myeloid leukemia (AML).
Researchers of Karlsruhe Institute of Technology (KIT) and of the FZI Research Center for Information Technology, an innovation partner of KIT, have now proposed an app that combines the advantages of a central and a decentralized approach and, thus, enhances privacy.
Endo Pharmaceuticals Inc., a subsidiary of Endo Health Solutions Inc. announced today that the U.S. Food and Drug Administration has issued a complete response letter regarding the New Drug Application for Endo's long-acting testosterone undecanoate injection, AVEED, for men diagnosed with hypogonadism.
› Verified 5 days ago
| Entity Name | Hyden Emergency Physicians, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497036776 PECOS PAC ID: 6103099163 Enrollment ID: O20111108000187 |
News Archive
Immunotherapy techniques developed in oncology to combat cancerous cells have great potential for fighting viruses.
Researchers at the Case Western Reserve University School of Medicine, with colleagues from the John P. Hussman Institute for Human Genomics at the University of Miami, Taub Institute for Research on Alzheimer's Disease and the Aging Brain, at Columbia University, and Wake Forest University School of Medicine will study the genomics of Alzheimer's disease (AD) in people with African heritage throughout the United States.
Genzyme Corporation announced results today from its CLASSIC I phase 3 trial comparing Clolar® (clofarabine) in combination with the chemotherapy agent cytarabine (ara-c) to cytarabine plus placebo in relapsed-refractory adult acute myeloid leukemia (AML).
Researchers of Karlsruhe Institute of Technology (KIT) and of the FZI Research Center for Information Technology, an innovation partner of KIT, have now proposed an app that combines the advantages of a central and a decentralized approach and, thus, enhances privacy.
Endo Pharmaceuticals Inc., a subsidiary of Endo Health Solutions Inc. announced today that the U.S. Food and Drug Administration has issued a complete response letter regarding the New Drug Application for Endo's long-acting testosterone undecanoate injection, AVEED, for men diagnosed with hypogonadism.
› Verified 5 days ago
| Entity Name | South Central Physicians Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427611854 PECOS PAC ID: 6507195492 Enrollment ID: O20210126001625 |
News Archive
Immunotherapy techniques developed in oncology to combat cancerous cells have great potential for fighting viruses.
Researchers at the Case Western Reserve University School of Medicine, with colleagues from the John P. Hussman Institute for Human Genomics at the University of Miami, Taub Institute for Research on Alzheimer's Disease and the Aging Brain, at Columbia University, and Wake Forest University School of Medicine will study the genomics of Alzheimer's disease (AD) in people with African heritage throughout the United States.
Genzyme Corporation announced results today from its CLASSIC I phase 3 trial comparing Clolar® (clofarabine) in combination with the chemotherapy agent cytarabine (ara-c) to cytarabine plus placebo in relapsed-refractory adult acute myeloid leukemia (AML).
Researchers of Karlsruhe Institute of Technology (KIT) and of the FZI Research Center for Information Technology, an innovation partner of KIT, have now proposed an app that combines the advantages of a central and a decentralized approach and, thus, enhances privacy.
Endo Pharmaceuticals Inc., a subsidiary of Endo Health Solutions Inc. announced today that the U.S. Food and Drug Administration has issued a complete response letter regarding the New Drug Application for Endo's long-acting testosterone undecanoate injection, AVEED, for men diagnosed with hypogonadism.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Raj B Patel, MD 2740 Josephine Dr, Henderson, NV 89044-0307 Ph: () - | Dr Raj B Patel, MD 901 Adams Blvd, Boulder City, NV 89005-2299 Ph: (702) 293-4111 |
News Archive
Immunotherapy techniques developed in oncology to combat cancerous cells have great potential for fighting viruses.
Researchers at the Case Western Reserve University School of Medicine, with colleagues from the John P. Hussman Institute for Human Genomics at the University of Miami, Taub Institute for Research on Alzheimer's Disease and the Aging Brain, at Columbia University, and Wake Forest University School of Medicine will study the genomics of Alzheimer's disease (AD) in people with African heritage throughout the United States.
Genzyme Corporation announced results today from its CLASSIC I phase 3 trial comparing Clolar® (clofarabine) in combination with the chemotherapy agent cytarabine (ara-c) to cytarabine plus placebo in relapsed-refractory adult acute myeloid leukemia (AML).
Researchers of Karlsruhe Institute of Technology (KIT) and of the FZI Research Center for Information Technology, an innovation partner of KIT, have now proposed an app that combines the advantages of a central and a decentralized approach and, thus, enhances privacy.
Endo Pharmaceuticals Inc., a subsidiary of Endo Health Solutions Inc. announced today that the U.S. Food and Drug Administration has issued a complete response letter regarding the New Drug Application for Endo's long-acting testosterone undecanoate injection, AVEED, for men diagnosed with hypogonadism.
› Verified 5 days ago
Douglas Franklin Thompson, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 901 Adams Blvd, Boulder City, NV 89005 Phone: 702-293-4111 Fax: 702-294-5717 | |
Derek Smith Meeks, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 901 Adams Blvd, Boulder City, NV 89005 Phone: 702-293-4111 |